Price range: $400.00 through $650.00
Thymosin Beta-4 (TB-4) is a naturally occurring peptide studied for its role in cellular migration, tissue remodeling, and actin-binding activity. Within controlled research environments, TB-4 is evaluated for its influence on regenerative signaling, angiogenic pathways, and structural protein dynamics.
As an actin-regulating peptide, TB-4 is commonly examined in laboratory models exploring soft-tissue signaling, recovery frameworks, and cellular repair mechanisms.
Research Name: Thymosin Beta-4
Alias: TB-4, Tβ4
Category: Regenerative signaling peptide
Primary Research Focus: Cellular migration, angiogenesis modeling, tissue-repair signaling
Format: Lyophilized powder
Upon reconstitution with an appropriate volume of bacteriostatic water, final concentration will vary depending on total diluent added. Researchers calculate concentration using the standard formula:
Total mg in vial ÷ Total mL added = mg per mL
For U-100 insulin syringes:
1 mL = 100 units
Units required are determined by dividing the desired mg amount by the final mg/mL concentration.
TB-4 is studied for its potential influence on:
Cellular Migration & Actin Dynamics
Actin polymerization signaling
Cell motility modeling
Cytoskeletal organization studies
Angiogenic Pathways
Vascular growth signaling
Endothelial cell activity
Microvascular remodeling frameworks
Tissue Remodeling & Recovery
Soft-tissue repair modeling
Connective tissue pathway evaluation
Post-stress regenerative signaling
Its mechanism centers around intracellular structural regulation rather than receptor agonism, distinguishing it from metabolic or endocrine peptides.
Within structured research environments, investigators may observe:
Dose-dependent variables
Localized tissue response changes
Regenerative marker fluctuations
Vascular signaling shifts
Localized observations
Mild redness at administration site
Temporary tissue sensitivity
Less frequent observations
Headache
Fatigue
Mild gastrointestinal discomfort
Monitoring intensity depends on protocol duration and whether TB-4 is evaluated independently or alongside other regenerative compounds.
Administration Frequency: Varies by study design
Common Study Duration: 4–8 weeks
Titration Strategy: Incremental adjustments to evaluate tissue-response signaling
Researchers often account for overlapping regenerative pathway activity when combining TB-4 with other repair-focused compounds.
Store lyophilized vial in a cool, dry environment.
Refrigerate after reconstitution.
Maintain sterile laboratory handling procedures at all times.
